Auro Laboratories Intrinsic Value
Auro Laboratories (AUROLAB) median intrinsic value is ₹101.20 from 9 valuation models (range ₹70–₹200), vs current price ₹234.75 — -56.9% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse AUROLAB FII DII holdings to track promoter, FII and institutional holdings.
AUROLAB Valuation Methods Summary — DCF, Graham Number & P/E
Auro Laboratories intrinsic value across 9 models vs current price ₹234.75 — upside/downside and value range per method. Read AUROLAB dividend yield for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹101.20 | ₹80.96 - ₹121.44 | -56.9% | EPS: ₹4.60, Sector P/E: 22x |
| Book Value Method | asset | ₹153.33 | ₹138.00 - ₹168.66 | -34.7% | Book Value/Share: ₹76.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹133.33 | ₹120.00 - ₹146.66 | -43.2% | Revenue/Share: ₹66.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹200.00 | ₹180.00 - ₹220.00 | -14.8% | EBITDA: ₹12.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹93.90 | ₹75.12 - ₹112.68 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹70.42 | ₹63.38 - ₹77.46 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹71.07 | ₹63.96 - ₹78.18 | -69.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹117.38 | ₹105.64 - ₹129.12 | -50.0% | ROE: 8.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹89.08 | ₹80.17 - ₹97.99 | -62.1% | EPS: ₹4.60, BVPS: ₹76.67 |
AUROLAB Intrinsic Value vs Market Price — All Valuation Models
Auro Laboratories fair value range ₹70–₹200 vs current market price ₹234.75 across 9 valuation models. For current market price and key ratios, visit Auro Laboratories share price chart.
AUROLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Auro Laboratories median intrinsic value ₹101.20, current price ₹234.75 — Trading Above Calculated Value by 56.9%, margin of safety -100.0%.
What is the intrinsic value of AUROLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Auro Laboratories (AUROLAB) is ₹101.20 (median value). With the current market price of ₹234.75, this represents a -56.9% variance from our estimated fair value.
The valuation range spans from ₹70.42 to ₹200.00, indicating ₹70.42 - ₹200.00.
Is AUROLAB undervalued or overvalued?
Based on our multi-method analysis, Auro Laboratories (AUROLAB) appears to be trading above calculated value by approximately 56.9%.
AUROLAB Financial Health — Key Ratios vs Industry Benchmarks
Auro Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.67 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 8.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.33x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
AUROLAB Cash Flow Quality — Operating & Free Cash Flow
Auro Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹5 Cr | ₹-7 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹19 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹-7 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |